Leading mRNA Vaccine Company Moderna Announces Expansion of MTC
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an expansion of the Moderna Technology Center (MTC) in Norwood, MA including more than doubling of space to transform the facility from a production and…
Altru Health System Powers Clinical Trial Offering with Deep Lens
Altru Health System Powers Clinical Trial Offering with Deep Lens
VIPER™ will identify and match eligible patients to oncology clinical trials faster and with improved efficiencies across Altru Health System’s...
Clinical Communication Co. Vocera to Acquire PatientSafe Solutions
Clinical Communication Co. Vocera to Acquire PatientSafe Solutions
Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, today announced it is acquiring PatientSafe Solutions based...
ZYUS Launches HOPE Phase 1 First in Human Clinical Trials
ZYUS Launches HOPE Phase 1 First in Human Clinical Trials
Phase 1a/1b clinical trials beginning April 2021 will assess the safety and tolerability of ZYUS’ lead drug product candidate in...
Oregon Oncology Specialists Integrates AI Clinical Trial Screening
Oregon Oncology Specialists Integrates AI Clinical Trial Screening
Deep Lens and Oregon Oncology Specialists today announced a strategic collaboration that will integrate Deep Lens’ artificial-intelligence (AI)-based clinical trial...